
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 989 | 981 | 1355 | 1260 | 1917 | 3240 |
Fund Return | -1.09% | -1.86% | 35.48% | 8% | 13.9% | 12.47% |
Place in category | 74 | 84 | 106 | 126 | 86 | 43 |
% in Category | 37 | 38 | 51 | 70 | 55 | 72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fondo Interacciones MF A | 13.69B | 1.54 | 10.40 | 5.59 | ||
Fondo Banorte IXE 27 M5 | 4.49B | -1.29 | 10.28 | - | ||
Fondo Banorte IXE 27 A | 4.49B | -0.84 | 13.40 | - | ||
Fondo Banorte IXE 27 APIE | 4.49B | -0.82 | 13.53 | - | ||
Fondo Banorte IXE 27 E1 | 4.49B | -1.10 | 11.57 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Scotia Internacional A | 19.44B | -2.58 | 16.03 | 18.90 | ||
Scotia Internacional C1E | 19.44B | -2.58 | 13.48 | - | ||
Scotia Internacional II0 | 19.44B | 58.80 | 10.91 | - | ||
Scotia Internacional S | 19.44B | -2.69 | 15.29 | - | ||
Scotia Internacional E | 1.24B | 58.07 | 9.05 | 16.95 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vanguard S&P 500 | US9229083632 | 51.65 | 468.45 | -5.20% | |
SPDR S&P 500 UCITS USD Acc | IE000XZSV718 | 43.00 | 11.50 | -4.20% | |
Technology Select Sector SPDR | US81369Y8030 | 1.61 | 183.76 | -5.88% | |
Financial Select Sector SPDR | US81369Y6059 | 1.13 | 44.54 | -6.62% | |
Health Care Select Sector SPDR | US81369Y2090 | 0.81 | 136.59 | -4.57% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Buy | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review